GLTO
Price
$2.96
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
3.92M
XERS
Price
$4.92
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
781.56M
75 days until earnings call
Interact to see
Advertisement

GLTO vs XERS

Header iconGLTO vs XERS Comparison
Open Charts GLTO vs XERSBanner chart's image
Galecto
Price$2.96
Change-$0.00 (-0.00%)
Volume$2
Capitalization3.92M
Xeris Biopharma Holdings
Price$4.92
Change-$0.00 (-0.00%)
Volume$378
Capitalization781.56M
GLTO vs XERS Comparison Chart
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. XERS commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Buy and XERS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (GLTO: $2.96 vs. XERS: $4.92)
Brand notoriety: GLTO and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 0% vs. XERS: 0%
Market capitalization -- GLTO: $3.92M vs. XERS: $781.56M
GLTO [@Biotechnology] is valued at $3.92M. XERS’s [@Biotechnology] market capitalization is $781.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLTO and XERS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 5 TA indicator(s) are bullish while XERS’s TA Score has 5 bullish TA indicator(s).

  • GLTO’s TA Score: 5 bullish, 2 bearish.
  • XERS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLTO is a better buy in the short-term than XERS.

Price Growth

GLTO (@Biotechnology) experienced а +1.54% price change this week, while XERS (@Biotechnology) price change was +2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.00%. For the same industry, the average monthly price growth was +5.57%, and the average quarterly price growth was -1.69%.

Reported Earning Dates

GLTO is expected to report earnings on Mar 19, 2025.

XERS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XERS($782M) has a higher market cap than GLTO($3.92M). XERS YTD gains are higher at: 45.133 vs. GLTO (-36.344). XERS has higher annual earnings (EBITDA): -13.99M vs. GLTO (-19.68M). XERS has more cash in the bank: 71.6M vs. GLTO (19.7M). GLTO has less debt than XERS: GLTO (32K) vs XERS (271M). XERS has higher revenues than GLTO: XERS (203M) vs GLTO (0).
GLTOXERSGLTO / XERS
Capitalization3.92M782M1%
EBITDA-19.68M-13.99M141%
Gain YTD-36.34445.133-81%
P/E RatioN/AN/A-
Revenue0203M-
Total Cash19.7M71.6M28%
Total Debt32K271M0%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLTOXERS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IFRX1.820.13
+7.69%
InflaRx NV
BDRX1.30N/A
N/A
Biodexa Pharmaceuticals plc
BE18.21N/A
N/A
Bloom Energy Corp
TRVI6.18N/A
N/A
Trevi Therapeutics
EMN81.36-0.12
-0.15%
Eastman Chemical Company

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with XERS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
N/A
XERS - GLTO
40%
Loosely correlated
N/A
VIVS - GLTO
38%
Loosely correlated
N/A
RGNX - GLTO
35%
Loosely correlated
N/A
RCKT - GLTO
35%
Loosely correlated
N/A
SYRE - GLTO
34%
Loosely correlated
+1.96%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
N/A
TRDA - XERS
49%
Loosely correlated
-0.91%
XNCR - XERS
48%
Loosely correlated
+2.26%
KRYS - XERS
46%
Loosely correlated
N/A
RCKT - XERS
46%
Loosely correlated
N/A
YMAB - XERS
45%
Loosely correlated
N/A
More